TCL Archive Seer Places Survival Now at Least At 45 Percent, Could Be As High As 50 Percent For 1973-79 Patients December 4, 1981
TCL Archive Clearinghouse Delves Into Carcinogenesis Issues – Test Validity, Interpretation, In Vitro Methods August 12, 1977
TCL Archive Cell Genesys Begins Phase II Trial Of Gvax Vaccine For Pancreatic Cancer. November 30, 2001
TCL Archive DCCR Gets Go Ahead For New Community Clinical Oncology Program, $600,000 – $1 Million a Year May 12, 1978
